Zacks Research Issues Positive Forecast for ACHC Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - Equities researchers at Zacks Research lifted their Q3 2025 earnings per share estimates for shares of Acadia Healthcare in a research note issued to investors on Monday, October 14th. Zacks Research analyst Z. Masood now anticipates that the company will post earnings per share of $1.05 for the quarter, up from their previous estimate of $1.01. The consensus estimate for Acadia Healthcare's current full-year earnings is $3.51 per share. Zacks Research also issued estimates for Acadia Healthcare's Q2 2026 earnings at $1.06 EPS, Q3 2026 earnings at $1.12 EPS and FY2026 earnings at $4.25 EPS.

Several other analysts also recently issued reports on the stock. Barclays lowered their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an "overweight" rating for the company in a research report on Monday, September 30th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a "hold" rating in a research note on Friday, August 2nd. Royal Bank of Canada reissued an "outperform" rating and issued a $94.00 price objective on shares of Acadia Healthcare in a research report on Friday, September 20th. KeyCorp assumed coverage on Acadia Healthcare in a research note on Friday, October 11th. They issued a "sector weight" rating for the company. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating and set a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Acadia Healthcare presently has a consensus rating of "Hold" and a consensus price target of $86.67.

Acadia Healthcare Stock Up 3.4 %

Shares of NASDAQ ACHC traded up $1.93 on Thursday, hitting $59.32. The company had a trading volume of 1,111,448 shares, compared to its average volume of 905,855. The firm has a market capitalization of $5.50 billion, a P/E ratio of -423.71, a PEG ratio of 1.57 and a beta of 1.29. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 12-month low of $53.22 and a 12-month high of $87.77. The business has a 50 day moving average of $71.13 and a two-hundred day moving average of $69.72.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The business had revenue of $796.00 million for the quarter, compared to analyst estimates of $784.38 million. During the same quarter in the previous year, the business posted $0.92 EPS. The business's quarterly revenue was up 8.8% on a year-over-year basis.

Institutional Trading of Acadia Healthcare

Hedge funds have recently bought and sold shares of the company. Blue Trust Inc. boosted its position in Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company's stock worth $36,000 after acquiring an additional 248 shares during the period. Mather Group LLC. bought a new position in Acadia Healthcare in the 1st quarter valued at about $48,000. GAMMA Investing LLC increased its stake in Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company's stock valued at $42,000 after buying an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Acadia Healthcare during the 2nd quarter worth about $59,000. Finally, nVerses Capital LLC acquired a new stake in shares of Acadia Healthcare in the 2nd quarter worth approximately $95,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.